St. Jude proceeds with first U.S. trial of hypertension device

06/7/2013 | MassDevice.com (Boston)

The FDA has granted St. Jude Medical an investigational device exemption to conduct the first U.S. clinical study of its EnligHTN multielectrode device, which uses radiofrequency energy to disrupt the renal nerves believed to control blood pressure. The trial will involve about 590 patients with drug-resistant hypertension.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health